News
ASCO 2025 phase 1b/2 study assessing 9MW2821, nectin-4 antibody drug conjugate, toripalimab in treatment-naïve patients, locally advanced or metastatic urothelial carcinoma.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback